Supporting the delivery of RECOVERY-RS

Trial logo

 

The RECOVERY-RS trial

A range of potential treatments have been suggested for COVID-19 but nobody knows if any of them will turn out to be more effective in helping people recover than the usual standard of hospital care which all patients will receive. The RECOVERY-RS trial will compare the effectiveness of three ventilation methods;

1. Continuous positive airway pressure (CPAP): this treatment applies mild to high air pressure on a continuous basis through a tightly fitted face mask. It keeps the airways continuously open in people who are able to breathe normally on their own, but need help keeping their airway clear.

2. High flow nasal oxygen (HFNO): this is a way of giving humidified (moistened) and warmed oxygen through tubes into the nose. The oxygen is delivered very quickly to help patients who have low oxygen levels and find breathing on their own difficult.

3. Standard care: standard treatment will involve oxygen delivered via a normal face mask or tubes in the nose.

Data from the trial will be regularly reviewed so that any effective treatment can be identified quickly and made available to all patients.

Useful links